Erratum: EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis (FASEB Journal (2014) 28 (4482-4496) DOI: 10.1096/fj.14-254300);EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis

FASEB Journal

Volumn 28, Issue 10, 2014, Pages 4482-4496

  Tonna, Stephen ^a,b   Takyar, Farzin M ^a,b   Vrahnas, Christina ^a,b,e   Crimeen Irwin, Blessing ^a,b   Ho, Patricia W M ^a   Poulton, Ingrid J ^a   Brennan, Holly J ^a   McGregor, Narelle E ^a   Allan, Elizabeth H ^a,f   Nguyen, Huynh ^c,d   Forwood, Mark R ^c,d   Tatarczuch, Liliana ^b   Mackie, Eleanor J ^b   Martin, T John ^a,b   Sims, Natalie A ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Bone matrix; Bone strength; Osteoclast; Osteocyte

Indexed keywords

CASPASE 8; EPHRIN B2; LIPOCORTIN 5; MESSENGER RNA; PARATHYROID HORMONE; EPHB2 PROTEIN, MOUSE; EPHB4 PROTEIN, MOUSE; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B4;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MINERALIZATION; BONE STRENGTH; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; MALE; MECHANICS; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NICK END LABELING; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; RIGIDITY; RNA INTERFERENCE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BONE DEVELOPMENT; C57BL MOUSE; CYTOLOGY; GENETICS; METABOLISM;

ANIMALS; ANNEXIN A5; APOPTOSIS; CALCIFICATION, PHYSIOLOGIC; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOGENESIS; RECEPTOR, EPHB2; RECEPTOR, EPHB4; SIGNAL TRANSDUCTION;

EID: 84907706404     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-254300ERR     Document Type: Erratum

References (57)

1. Hirai, H., Maru, Y., Hagiwara, K., Nishida, J., and Takaku, F. (1987) A novel putative tyrosine kinase receptor encoded by the eph gene. Science 238, 1717-1720
2. Pasquale, E. B. (2010) Eph receptors and ephrins in cancer: bidirectional signaling and beyond. Nat. Rev. Cancer 10, 165-180
3. Murai, K. K., and Pasquale, E. B. (2003) 'Eph'ective signaling: forward, reverse and crosstalk. J. Sci. 116, 2823-2832
4. Irie, N., Takada, Y., Watanabe, Y., Matsuzaki, Y., Naruse, C., Asano, M., Iwakura, Y., Suda, T., and Matsuo, K. (2009) Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J. Biol. Chem. 284, 14637-14644
5. Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., and Matsuo, K. (2006) Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 4, 111-121
6. Arthur, A., Zannettino, A., Panagopoulos, R., Koblar, S. A., Sims, N. A., Stylianou, C., Matsuo, K., and Gronthos, S. (2011) EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation. Bone 48, 533-542
7. Allan, E. H., Hausler, K. D., Wei, T., Gooi, J. H., Quinn, J. M., Crimeen-Irwin, B., Pompolo, S., Sims, N. A., Gillespie, M. T., Onyia, J. E., and Martin, T. J. (2008) EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J. Bone Miner. Res. 23, 1170-1181
8. Takyar, F. M., Tonna, S., Ho, P. W., Crimeen-Irwin, B., Baker, E. K., Martin, T. J., and Sims, N. A. (2013) EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone. J. Bone Miner. Res. 28, 912-925
9. Frost, H. M. (1964) Dynamics of bone remodeling. In Bone Biodynamics (Frost, H. M., ed), pp. 315-333, Little, Brown & Co., Boston
10. Parfitt, A. M. (1996) Hormonal influences on bone remodeling and bone loss: application to the management of primary hyperparathyroidism. Ann. Int. Med. 125, 413-415
11. Sims, N. A., and Martin, T. J. (2014) Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. BoneKEy Rep. 3, 481
12. Lindsay, R., Zhou, H., Cosman, F., Nieves, J., Dempster, D. W., and Hodsman, A. B. (2007) Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium. J. Bone Miner. Res. 22, 495-502
13. Miao, D., He, B., Jiang, Y., Kobayashi, T., Soroceanu, M. A., Zhao, J., Su, H., Tong, X., Amizuka, N., Gupta, A., Genant, H. K., Kronenberg, H. M., Goltzman, D., and Karaplis, A. C. (2005) Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J. Clin. Invest. 115, 2402-2411
14. Martin, T. J., Allan, E. H., Ho, P. W., Gooi, J. H., Quinn, J. M., Gillespie, M. T., Krasnoperov, V., and Sims, N. A. (2010) Communication between EphrinB2 and EphB4 within the osteoblast lineage. Adv. Exp. Med. Biol. 658, 51-60
15. Rodda, S. J., and McMahon, A. P. (2006) Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231-3244
16. Gerety, S. S., and Anderson, D. J. (2002) Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 129, 1397-1410
17. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P., and Kato, S. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823
18. Kertesz, N., Krasnoperov, V., Reddy, R., Leshanski, L., Kumar, S. R., Zozulya, S., and Gill, P. S. (2006) The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood 107, 2330-2338
19. Davydova, N., Streltsov, V. A., Roufail, S., Lovrecz, G. O., Stacker, S. A., Adams, T. E., and Achen, M. G. (2012) Preparation of human vascular endothelial growth factor-D for structural and preclinical therapeutic studies. Protein Express. Purif. 82, 232-239
20. Koolpe, M., Burgess, R., Dail, M., and Pasquale, E. B. (2005) EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J. Biol. Chem. 280, 17301-17311
21. Walker, E. C., Poulton, I. J., McGregor, N. E., Ho, P. W., Allan, E. H., Quach, J. M., Martin, T. J., and Sims, N. A. (2012) Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. J. Bone Miner. Res. 27, 902-912
22. Johnson, R. W., Brennan, H. J., Vrahnas, C., Poulton, I. J., McGregor, N. E., Standal, T., Walker, E. C., Koh, T. T., Nguyen, H., Walsh, N. C., Forwood, M. R., Martin, T. J., and Sims, N. A. (2014) The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation. J. Bone Miner. Res. 29, 1492-1505
23. Allan, E. H., Ho, P. W., Umezawa, A., Hata, J., Makishima, F., Gillespie, M. T., and Martin, T. J. (2003) Differentiation potential of a mouse bone marrow stromal cell line. J. Cell. Biochem. 90, 158-169
24. Quinn, J. M., Sims, N. A., Saleh, H., Mirosa, D., Thompson, K., Bouralexis, S., Walker, E. C., Martin, T. J., and Gillespie, M. T. (2008) IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice. J. Immunol. 181, 5720-5729
25. Flanagan, J. G., Cheng, H. J., Feldheim, D. A., Hattori, M., Lu, Q., and Vanderhaeghen, P. (2000) Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos. Methods Enzymol. 327, 19-35
26. Houssami, S., Findlay, D. M., Brady, C. L., Myers, D. E., Martin, T. J., and Sexton, P. M. (1994) Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinology 135, 183-190
27. Dickins, R. A., Hemann, M. T., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G. J., and Lowe, S. W. (2005) Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Gen. 37, 1289-1295
28. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408
29. Zhou, R. (1998) The Eph family receptors and ligands. Pharmacol. Ther. 77, 151-181
30. Zhang, C., Cho, K., Huang, Y., Lyons, J. P., Zhou, X., Sinha, K., McCrea, P. D., and de Crombrugghe, B. (2008) Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc. Natl. Acad. Sci. U. S. A. 105, 6936-6941
31. Flanagan, J. G., and Vanderhaeghen, P. (1998) The ephrins and Eph receptors in neural development. Ann. Rev. Neurosci. 21, 309-345
32. Noren, N. K., Yang, N. Y., Silldorff, M., Mutyala, R., and Pasquale, E. B. (2009) Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. Biochem. J. 422, 433-442
33. Paic, F., Igwe, J. C., Nori, R., Kronenberg, M. S., Franceschetti, T., Harrington, P., Kuo, L., Shin, D. G., Rowe, D. W., Harris, S. E., and Kalajzic, I. (2009) Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 45, 682-692
34. Sabatakos, G., Sims, N. A., Chen, J., Aoki, K., Kelz, M. B., Amling, M., Bouali, Y., Mukhopadhyay, K., Ford, K., Nestler, E. J., and Baron, R. (2000) Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6, 985-990
35. Keller, H., and Kneissel, M. (2005) SOST is a target gene for PTH in bone. Bone 37, 148-158
36. Ma, Y. L., Cain, R. L., Halladay, D. L., Yang, X., Zeng, Q., Miles, R. R., Chandrasekhar, S., Martin, T. J., and Onyia, J. E. (2001) Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142, 4047-4054
37. Melsen, F., and Mosekilde, L. (1980) Trabecular bone mineralization lag time determined by tetracycline double-labeling in normal and certain pathological conditions. Acta Pathol. Microbiol. Scand. A 88, 83-88
38. Sarathchandra, P., Pope, F. M., Kayser, M. V., and Ali, S. Y. (2000) A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype. J. Pathol. 192, 385-395
39. Boyadjiev, S. A., Fromme, J. C., Ben, J., Chong, S. S., Nauta, C., Hur, D. J., Zhang, G., Hamamoto, S., Schekman, R., Ravazzola, M., Orci, L., and Eyaid, W. (2006) Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking. Nat. Gen. 38, 1192-1197
40. Townley, A. K., Feng, Y., Schmidt, K., Carter, D. A., Porter, R., Verkade, P., and Stephens, D. J. (2008) Efficient coupling of Sec23-Sec24 to Sec13-Sec31 drives COPII-dependent collagen secretion and is essential for normal craniofacial development. J. Cell Sci. 121, 3025-3034
41. Wilson, D. G., Phamluong, K., Li, L., Sun, M., Cao, T. C., Liu, P. S., Modrusan, Z., Sandoval, W. N., Rangell, L., Carano, R. A., Peterson, A. S., and Solloway, M. J. (2011) Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. J. Cell Biol. 193, 935-951
42. Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274-282
43. Almeida, M., Han, L., Martin-Millan, M., O'Brien, C. A., and Manolagas, S. C. (2007) Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem. 282, 27298-27305
44. Aguirre, J. I., Plotkin, L. I., Stewart, S. A., Weinstein, R. S., Parfitt, A. M., Manolagas, S. C., and Bellido, T. (2006) Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J. Bone Miner. Res. 21, 605-615
45. Cerri, P. S. (2005) Osteoblasts engulf apoptotic bodies during alveolar bone formation in the rat maxilla. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 286, 833-840
46. Boskey, A. L., Gadaleta, S., Gundberg, C., Doty, S. B., Ducy, P., and Karsenty, G. (1998) Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23, 187-196
47. Van Bezooijen, R. L., Roelen, B. A., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S. E., ten Dijke, P., and Lowik, C. W. (2004) Sclerostin is an osteocyteexpressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199, 805-814
48. Scehnet, J. S., Ley, E. J., Krasnoperov, V., Liu, R., Manchanda, P. K., Sjoberg, E., Kostecke, A. P., Gupta, S., Kumar, S. R., and Gill, P. S. (2009) The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood 113, 254-263
49. Weiler, S., Rohrbach, V., Pulvirenti, T., Adams, R., Ziemiecki, A., and Andres, A. C. (2009) Mammary epithelial-specific knockout of the ephrin-B2 gene leads to precocious epithelial cell death at lactation. Dev. Growth Differ. 51, 809-819
50. Martiny-Baron, G., Korff, T., Schaffner, F., Esser, N., Eggstein, S., Marme, D., and Augustin, H. G. (2004) Inhibition of tumor growth and angiogenesis by soluble EphB4. Neoplasia 6, 248-257
51. Masood, R., Xia, G., Smith, D. L., Scalia, P., Still, J. G., Tulpule, A., and Gill, P. S. (2005) Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood 105, 1310-1318
52. Yadav, M. C., de Oliveira, R. C., Foster, B. L., Fong, H., Cory, E., Narisawa, S., Sah, R. L., Somerman, M., Whyte, M. P., and Millan, J. L. (2012) Enzyme replacement prevents enamel defects in hypophosphatasia mice. J. Bone Miner. Res. 27, 1722-1734
53. Kelly, P. N., and Strasser, A. (2011) The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ. 18, 1414-1424
54. Nagase, Y., Iwasawa, M., Akiyama, T., Kadono, Y., Nakamura, M., Oshima, Y., Yasui, T., Matsumoto, T., Hirose, J., Nakamura, H., Miyamoto, T., Bouillet, P., Nakamura, K., and Tanaka, S. (2009) Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclasts. J. Biol. Chem. 284, 36659-36669
55. Xing, W., Kim, J., Wergedal, J., Chen, S. T., and Mohan, S. (2010) Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1. Mol. Cell. Biol. 30, 711-721
56. Roche, B., David, V., Vanden-Bossche, A., Peyrin, F., Malaval, L., Vico, L., and Lafage-Proust, M. H. (2012) Structure and quantification of microvascularisation within mouse long bones: what and how should we measure? Bone 50, 390-399
57. Arthur, A., Panagopoulos, R. A., Cooper, L., Menicanin, D., Parkinson, I. H., Codrington, J. D., Vandyke, K., Zannettino, A. C., Koblar, S. A., Sims, N. A., Matsuo, K., and Gronthos, S. (2013) EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair. J. Bone Miner. Res. 28, 926-935